Beximco Pharmaceuticals Limited (LON:BXP – Get Free Report)’s share price hit a new 52-week high during trading on Wednesday . The stock traded as high as GBX 57.40 and last traded at GBX 55.90, with a volume of 18381 shares. The stock had previously closed at GBX 56.
Beximco Pharmaceuticals Trading Up 1.6%
The company has a quick ratio of 0.37, a current ratio of 4.13 and a debt-to-equity ratio of 5.27. The stock has a market capitalization of £249.38 million, a P/E ratio of 0.03 and a beta of 0.25. The company has a fifty day simple moving average of GBX 50.09 and a two-hundred day simple moving average of GBX 45.17.
Beximco Pharmaceuticals Company Profile
Beximco Pharma is a leading manufacturer and exporter of medicines based in Bangladesh. Incorporated in 1976, the Company started its operation by importing products from Bayer, Germany and Upjohn, USA and selling them in the local market. In 1980, Beximco Pharma began manufacturing of these products under licensing arrangement and in 1983 launched its own formulation brands. Since its inception, the Company remains committed to health and wellbeing of people across all the continents by providing access to contemporary medicines.
Recommended Stories
- Five stocks we like better than Beximco Pharmaceuticals
- Microsoft’s Sell-Off May Be a Gift, Not a Warning
- SK hynix Triggers $28B Defense Against Tech Selloff
- Coherent Stock Is Cooling Off Just as Its AI Thermal Opportunity Heats Up
- Moderna’s 177% Surge Has Investors Asking What Comes Next
Receive News & Ratings for Beximco Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Beximco Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
